Clinical Trials Results - National Cancer Institute


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?

	NCI Highlights


	High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E Past Highlights



Results: 1 -10 of 19 Show results per page	View Search Criteria \| Help With Results

Last Modified: 4/20/2007 First Published: 11/1/2002


1.		Phase III Randomized Study of Gemcitabine With or Without Pemetrexed Disodium in Patients With Stage II, III, or IV Unresectable Pancreatic Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				18 and over				NCI, Pharmaceutical / Industry				CWRU-010224M NCI-G02-2125, LILLY-H3E-MC-JMES, LILLY-LILY-1201, NCT00049426

Last Modified: 6/1/1992


2.		Phase I/II Study of Lometrexol in Patients with Ovarian Adenocarcinoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Supportive care, Treatment				Completed				18 and over								MSKCC-91173 NCI-V92-0026


3.		Phase I/II CT 2106 and 5-FU/FA in Colorectal Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Completed				18 and over				Pharmaceutical / Industry				CAM201 NCT00291785

Last Modified: 5/8/2007 First Published: 6/1/1995


4.		Phase II Randomized Study of High-Dose Folic Acid for the Prevention of Colorectal Cancer in Patients With Resected Adenomatous Polyps (Summary Last Modified 12/2001)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Prevention				Closed				21 and over				NCI				E-8292 NCI-P95-0066, NCT00002650

Last Modified: 11/1/2002 First Published: 4/1/2002


5.		Phase II Study of Lometrexol and Folic Acid in Patients With Previously Treated Stage IIIB or IV Non-Small Cell Lung Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				18 and over				Pharmaceutical / Industry				TULA-T064031 USO-01103, NCT00033722

Last Modified: 7/12/2007


6.		Phase II Study of Allogeneic and Syngeneic Bone Marrow Transplantation in Patients with High-Risk Myelodysplastic Syndrome (Summary Last Modified 06/93)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				6 months to 65 years								EUC-47491 NCI-V92-0171


7.		Chemoprevention With Folic Acid

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Prevention				Completed				18 to 80				Other				ONCO-021-98S NCT00018551


8.		Pemetrexed as Second-Line Therapy in Treating Patients With Hormone Refractory Prostate Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				18 and over				Other				HOG GU03-67 NCT00216099


9.		A Study of Pemetrexed and Folic Acid Given Before Surgery (Neoadjuvant Treatment) to Patients With Rectal Cancer.

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Biomarker/Laboratory analysis, Treatment				Completed				18 and over				Pharmaceutical / Industry				9732 H3E-MC-S077, NCT00330915


10.		Study of Pralatrexate With Vitamin B12 and Folic Acid in Patients With Relapsed or Refractory Peripheral T-Cell Lymphoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				18 and over				Pharmaceutical / Industry				PROPEL PDX-008, NCT00364923

Select All on One Page


					1 2 Next >

| | | | | | | |

A Service of the National Cancer Institute